Asian Stock: Celltrion Inc.

By Andrew Stotz of Become A Better Investor

May 20, 2025 at 11:00 AM EDT

Celltrion Incorporated is one of Korea’s biggest exporters by value of biosimilar pharmaceutical products.

Company: Celltrion Incorporated

Bloomberg ticker: 068270 KS

Market cap: US$24,773m

Background: Celltrion Incorporated is one of Korea’s biggest exporters by value of biosimilar pharmaceutical products; a biosimilar is a cheaper version of a biopharmaceutical, a type of drug which is derived from biological rather than chemical sources. Like with a generic drug, the development costs are low.

World Class Benchmarking of Celltrion Inc

(Click on image to enlarge)

Profitable Growth rank of 9 was down compared to the prior period’s 7th rank
This is poor performance compared to 350 large Health Care companies worldwide
Profitability rank of 8 was better than its Growth rank of 9
Profitability rank of 8 was down compared to the prior period’s 6th rank
This is below average performance compared to peers
Growth rank of 9 was down compared to the prior period’s 6th rank
This is poor performance compared to peers

More By This Author:

Asian Stock: Jinan Acetate Chemical
Asian Stock: Bumi Resources Minerals
Asian Stock - Bangkok Dusit Medical Services

Disclaimer:

This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.

Comments

Back to all articles